Qiting Wu

1.4k citations

26 papers · 745 indexed · h-index 13

Impact in

Oncology top 5%
- CAR-T cell therapy research
- Cancer Immunotherapy and Biomarkers
Immunology top 10%
- Immune Cell Function and Interaction
- Immunotherapy and Immune Responses

Papers in ⓘ

Oncology 17
- CAR-T cell therapy research 15
- Cancer Immunotherapy and Biomarkers 3
Immunology 12
- Immune Cell Function and Interaction 11
- Immunotherapy and Immune Responses 6

Co-authors: Peng Li (14 shared papers)Yao Yao (14 shared papers)Ruocong Zhao (9 shared papers)Duanqing Pei (5 shared papers)Simiao Lin (7 shared papers)Yunxin Lai (5 shared papers)Xinru Wei (6 shared papers)Pentao Liu (6 shared papers)
Journals: Frontiers in Immunology (3 papers)Biomarker Research (2 papers)OncoImmunology (2 papers)Scientific Reports (1 paper)Molecular Therapy — Oncolytics (1 paper)
Partner nations: China United Kingdom Hong Kong

In The Last Decade

Qiting Wu

23 papers receiving 732 citations

Peers

Countries citing papers authored by Qiting Wu

Since Specialization

Citations

This map shows the geographic impact of Qiting Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Qiting Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Qiting Wu more than expected).

Fields of papers citing papers by Qiting Wu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Qiting Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Qiting Wu. The network helps show where Qiting Wu may publish in the future.

Co-authors

The 25 scholars most cited alongside Qiting Wu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Qiting Wu Line = papers co-authored together Qiting Wu links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 26 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Anti-GPC3-CAR T Cells Suppress the Growth of Tumor Cells in Patient-Derived Xenografts of Hepatocellular Carcinoma Frontiers in Immunology ·Zhiwu Jiang, Xiaofeng Jiang, Suimin Chen, Yunxin Lai, Xinru Wei, Baiheng Li, Simiao Lin, Suna Wang, Qiting Wu, Qiubin Liang, Qifa Liu, Muyun Peng, Fenglei Yu, Jianyu Weng, Xin Du, Duanqing Pei, Pentao Liu, Yao Yao, Ping Xue, Peng Li	2017	181
2	PSCA and MUC1 in non-small-cell lung cancer as targets of chimeric antigen receptor T cells OncoImmunology ·Xinru Wei, Yunxin Lai, Jin Li, Le Qin, Youdi Xu, Ruocong Zhao, Baiheng Li, Simiao Lin, Suna Wang, Qiting Wu, Qiubin Liang, Muyun Peng, Fenglei Yu, Yangqiu Li, Xuchao Zhang, Yi‐Long Wu, Pentao Liu, Duanqing Pei, Yao Yao, Peng Li	2017	106
3	Incorporation of a hinge domain improves the expansion of chimeric antigen receptor T cells Journal of Hematology & Oncology ·Le Qin, Yunxin Lai, Ruocong Zhao, Xinru Wei, Jianyu Weng, Peilong Lai, Baiheng Li, Simiao Lin, Suna Wang, Qiting Wu, Qiubin Liang, Yangqiu Li, Xuchao Zhang, Yi‐Long Wu, Pentao Liu, Yao Yao, Duanqing Pei, Xin Du, Peng Li	2017	79
4	Toll-like receptor 2 costimulation potentiates the antitumor efficacy of CAR T Cells Leukemia ·Yunxin Lai, Jianyu Weng, Xuefeng Wei, Le Qin, Peilong Lai, Ruocong Zhao, Zhiwu Jiang, B Li, Shudong Lin, Shixiang Wang, Qiting Wu, Zhaoyang Tang, P Liu, Duanqing Pei, Yikun Yao, Xin Du, Peng Li	2017	78
5	Chimeric antigen receptor T cells targeting PD-L1 suppress tumor growth Biomarker Research ·Le Qin, Ruocong Zhao, Dongmei Chen, Xinru Wei, Qiting Wu, Youguo Long, Zhiwu Jiang, Yangqiu Li, Haipeng Wu, Xuchao Zhang, Yi‐Long Wu, Shuzhong Cui, Wei Wei, Huihui Yao, Zixia Liu, Su Mei Cao, Yao Yao, Zhenfeng Zhang, Peng Li	2020	51
6	Human Hyaluronidase PH20 Potentiates the Antitumor Activities of Mesothelin-Specific CAR-T Cells Against Gastric Cancer Frontiers in Immunology ·Ruocong Zhao, Yuanbin Cui, Yongfang Zheng, Shanglin Li, Jiang Lv, Qiting Wu, Youguo Long, Suna Wang, Yao Yao, Wei Wei, Jie Yang, Bin-Chao Wang, Zhenfeng Zhang, Hui Zeng, Yangqiu Li, Peng Li	2021	50
7	PSCA is a target of chimeric antigen receptor T cells in gastric cancer Biomarker Research ·Di Wu, Jiang Lv, Ruocong Zhao, Zhiping Wu, Diwei Zheng, Jingxuan Shi, Simiao Lin, Suna Wang, Qiting Wu, Youguo Long, Peng Li, Yao Yao	2020	34
8	DNAX-activating protein 10 co-stimulation enhances the anti-tumor efficacy of chimeric antigen receptor T cells OncoImmunology ·Ruocong Zhao, Lin Cheng, Zhiwu Jiang, Xinru Wei, Baiheng Li, Qiting Wu, Suna Wang, Simiao Lin, Youguo Long, Xuchao Zhang, Yi‐Long Wu, Xin Du, Duanqing Pei, Pentao Liu, Yangqiu Li, Shuzhong Cui, Yao Yao, Peng Li	2018	26
9	Disruption of CISH promotes the antitumor activity of human T cells and decreases PD-1 expression levels Molecular Therapy — Oncolytics ·Jiang Lv, Le Qin, Ruocong Zhao, Di Wu, Zhiping Wu, Diwei Zheng, Siyu Li, Mintao Luo, Qiting Wu, Youguo Long, Zhaoyang Tang, Yan‐Lai Tang, Xue‐Qun Luo, Yao Yao, Li-Hua Yang, Peng Li	2022	23
10	Bispecific CAR-T cells targeting FAP and GPC3 have the potential to treat hepatocellular carcinoma SHILAP Revista de lepidopterología ·Linfu Zhou, Yao Li, Diwei Zheng, Yongfang Zheng, Yuanbin Cui, Le Qin, Zhaoyang Tang, Dongdong Peng, Qiting Wu, Youguo Long, Yao Yao, Nathalie Wong, James Y. Lau, Peng Li	2024	20
11	Chimeric CTLA4-CD28-CD3z T Cells Potentiate Antitumor Activity Against CD80/CD86–Positive B Cell Malignancies Frontiers in Immunology ·Shouheng Lin, Lin Cheng, Wei Ye, Shanglin Li, Diwei Zheng, Le Qin, Qiting Wu, Youguo Long, Simiao Lin, Suna Wang, Guohua Huang, Peng Li, Yao Yao, Xiaofang Sun	2021	19
12	Prevalence and Predictors of Chronic Pain with Two-Year Follow-Up After Knee Arthroplasty Journal of Pain Research ·Meimei Tian, Zihua Li, Xujuan Chen, Qiting Wu, Huimin Shi, Yuchang Zhu, Yan Shi	2022	15
13	Novel variants in PAX6 gene caused congenital aniridia in two Chinese families Eye ·Rundong Zhang, Siyuan Linpeng, Xianda Wei, H Li, Yihua Huang, Jifeng Guo, Qiting Wu, Desheng Liang, Long Wu	2017	13
14	CD318 is a target of chimeric antigen receptor T cells for the treatment of colorectal cancer Clinical and Experimental Medicine ·Ming Li, Shanglin Li, Ruocong Zhao, Jiang Lv, Diwei Zheng, Le Qin, Siyu Li, Qiting Wu, Youguo Long, Zhaoyang Tang, Yan‐Lai Tang, Lihua Yang, Yao Yao, Xue‐Qun Luo, Peng Li	2022	10
15	CRISPR/Cas9-Mediated Deletion of Foxn1 in NOD/SCID/IL2rg−/− Mice Results in Severe Immunodeficiency Scientific Reports ·Xinru Wei, Yunxin Lai, Baiheng Li, Le Qin, Youdi Xu, Simiao Lin, Suna Wang, Qiting Wu, Qiubin Liang, Guohua Huang, Qiuhua Deng, Pentao Liu, Donghai Wu, Liangxue Lai, Yao Yao, Peng Li	2017	8
16	Phyllanthuse emblica polyphenols: Optimization of high-voltage pulsed electric field assisted extraction, an antioxidant and anti-inflammatory effects in vitro SHILAP Revista de lepidopterología ·Lin Ye, Luo Wan, Yanfeng Nie, Min Chen, Qiting Wu, Peng Yan, Huaiqing Sun, Yunlin Pei, Chaowan Guo, Ying Lin	2024	8
17	The onco-embryonic antigen ROR1 is a target of chimeric antigen T cells for colorectal cancer International Immunopharmacology ·Shangsen Meng, Ming Li, Le Qin, Jiang Lv, Di Wu, Diwei Zheng, Heng Jia, Dongmei Chen, Qiting Wu, Youguo Long, Zhaoyang Tang, Yan‐Lai Tang, Lihua Yang, Yao Yao, Xue‐Qun Luo, Peng Li	2023	7
18	B₁ inhomogeneity corrected CEST MRI based on direct saturation removed omega plot model at 5T Magnetic Resonance in Medicine ·Qiting Wu, Pengcheng Gong, Shengping Liu, Ye Li, Dong Liang, Hairong Zheng, Yin Wu	2024	4
19	Fast and robust pulsed chemical exchange saturation transfer (CEST) MRI using a quasi-steady-state (QUASS) algorithm at 3 T Magnetic Resonance Imaging ·Qiting Wu, Yulong Qi, Pengcheng Gong, Bingsheng Huang, Guanxun Cheng, Dong Liang, Hairong Zheng, Phillip Zhe Sun, Yin Wu	2023	3
20	DNMT1 inhibition reprograms T cells to NK-like cells with potent antitumor activity Science Immunology ·Yao Li, Jiongliang Wang, Linfu Zhou, Wenbin Gu, Le Qin, Dongdong Peng, Shanglin Li, Diwei Zheng, Qiting Wu, Youguo Long, Yao Yao, Shouheng Lin, Mingwei Sun, Xiaofei Zhang, Jie Wang, Pentao Liu, Xiangqian Kong, Peng Li	2025	3

About Qiting Wu

Qiting Wu is a scholar working on Oncology, Immunology, Radiology, Nuclear Medicine and Imaging, Biophysics and Materials Chemistry, having authored 26 papers that have together received 745 indexed citations. Recurring topics across this work include CAR-T cell therapy research (15 papers), Immune Cell Function and Interaction (11 papers), Immunotherapy and Immune Responses (6 papers), Lanthanide and Transition Metal Complexes (4 papers), Advanced MRI Techniques and Applications (4 papers), Cancer Immunotherapy and Biomarkers (3 papers), MRI in cancer diagnosis (3 papers) and Virus-based gene therapy research (2 papers). The work is most often cited by research in Oncology (573 citations), Immunology (323 citations), Hepatology (47 citations), Genetics (141 citations) and Biomedical Engineering (173 citations). Qiting Wu has collaborated with scholars based in China, United Kingdom and Hong Kong. Frequent co-authors include Peng Li, Yao Yao, Ruocong Zhao, Duanqing Pei, Simiao Lin, Yunxin Lai, Xinru Wei, Pentao Liu, Baiheng Li and Le Qin. Their work appears in journals such as Frontiers in Immunology, Biomarker Research, OncoImmunology, Scientific Reports and Molecular Therapy — Oncolytics.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact